MP
MapLight Therapeutics, Inc.
MPLT · NASDAQ
$10.92 -2.59% (-$0.29)
1M -3.87%
Market Cap $463.4M
P/E Ratio -
Div. Yield -
ROE 63.84%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.33x
P/E N/A
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 180.05%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 69.35%
Asset turnover 0.00x
ROE 63.84%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 16.52x
Int. coverage N/A
Stability
30 /100
Unstable Beta 2.57x
Profitable years 0
EPS volatility 30.04%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MPLT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher A. Kroeger
Employees
133
Headquarters
Redwood City
Upcoming events
03 DEC
Earnings
Upcoming earnings report